Cargando…
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort
BACKGROUND: Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ between patients with an acute myocardial infarction (MI) and he...
Autores principales: | Meziani, Sara, Ferrannini, Giulia, Bjerre, Mette, Hansen, Troels K., Ritsinger, Viveca, Norhammar, Anna, Gyberg, Viveca, Näsman, Per, Rydén, Lars, Mellbin, Linda G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270763/ https://www.ncbi.nlm.nih.gov/pubmed/35804351 http://dx.doi.org/10.1186/s12933-022-01562-0 |
Ejemplares similares
-
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study
por: Fortin, Elena, et al.
Publicado: (2022) -
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
por: Ferrannini, Giulia, et al.
Publicado: (2021) -
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
por: Ritsinger, Viveca, et al.
Publicado: (2021) -
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
por: Ritsinger, Viveca, et al.
Publicado: (2020) -
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia: Experiences from the randomized, controlled SOCOGAMI trial
por: Fortin, Elena, et al.
Publicado: (2023)